An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients

BackgroundThis study aimed to identify autophagy-related long non-coding RNAs (lncRNAs) associated with progression of neuroblastoma (NB), and to build an autophagy-related lncRNA signature that helps to predict progression-free survival (PFS) of NB.MethodsThree independent gene expression datasets...

Full description

Bibliographic Details
Main Authors: Jing Wang, Xinyao Meng, Ke Chen, Jiexiong Feng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1014845/full
_version_ 1797987761897078784
author Jing Wang
Xinyao Meng
Ke Chen
Jiexiong Feng
author_facet Jing Wang
Xinyao Meng
Ke Chen
Jiexiong Feng
author_sort Jing Wang
collection DOAJ
description BackgroundThis study aimed to identify autophagy-related long non-coding RNAs (lncRNAs) associated with progression of neuroblastoma (NB), and to build an autophagy-related lncRNA signature that helps to predict progression-free survival (PFS) of NB.MethodsThree independent gene expression datasets were utilized in this study. Autophagy-related genes (ARG) associated with PFS of NB patients were firstly identified by univariate Cox survival analysis. lncRNAs correlated with those PFS-related ARGs were then identified. The least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox regression analyses were performed to select out those lncRNAs with the best prognostic value for PFS. The Receiver Operating Characteristic (ROC) and Area Under Curve (AUC) analyses were performed to assess the prediction accuracy.ResultsFour autophagy-related lncRNAs (AL356599.1, AC022075.1, AC020928.1 and LINC02076) were found to be with the best prognostic value and integrated into a four-lncRNA risk signature for predicting PFS of NB patients. The four-lncRNA signature significantly stratify NB patients into two risk groups, with high-risk group has significantly poorer PFS than the low-risk group. The prognostic role of the lncRNA signature was independent with other clinical risk factors. The ROC curves revealed that the lncRNA signature has a good performance in predicting PFS (AUC > 0.70). A nomogram based on COG (Children’s Oncology Group) risk and the lncRNA risk score was constructed, showing good prediction accuracy (C-index = 0.700). The prognostic ability of the nomogram was better than that of COG risk alone (AUC = 0.790 versus AUC = 0.748). GSEA analyses revealed that multiple autophagy-related gene sets are significantly enriched in the low-risk group.ConclusionsWe identified an autophagy-related four-lncRNA signature that could help to predict the PFS of NB patients. Autophagy-related gene sets are significantly enriched in low-risk group, suggesting tumor suppressive roles of autophagy in NB.
first_indexed 2024-04-11T07:53:19Z
format Article
id doaj.art-01d8481c24e143f68f660e8163e7f4aa
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T07:53:19Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-01d8481c24e143f68f660e8163e7f4aa2022-12-22T04:36:00ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-12-011210.3389/fonc.2022.10148451014845An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patientsJing WangXinyao MengKe ChenJiexiong FengBackgroundThis study aimed to identify autophagy-related long non-coding RNAs (lncRNAs) associated with progression of neuroblastoma (NB), and to build an autophagy-related lncRNA signature that helps to predict progression-free survival (PFS) of NB.MethodsThree independent gene expression datasets were utilized in this study. Autophagy-related genes (ARG) associated with PFS of NB patients were firstly identified by univariate Cox survival analysis. lncRNAs correlated with those PFS-related ARGs were then identified. The least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox regression analyses were performed to select out those lncRNAs with the best prognostic value for PFS. The Receiver Operating Characteristic (ROC) and Area Under Curve (AUC) analyses were performed to assess the prediction accuracy.ResultsFour autophagy-related lncRNAs (AL356599.1, AC022075.1, AC020928.1 and LINC02076) were found to be with the best prognostic value and integrated into a four-lncRNA risk signature for predicting PFS of NB patients. The four-lncRNA signature significantly stratify NB patients into two risk groups, with high-risk group has significantly poorer PFS than the low-risk group. The prognostic role of the lncRNA signature was independent with other clinical risk factors. The ROC curves revealed that the lncRNA signature has a good performance in predicting PFS (AUC > 0.70). A nomogram based on COG (Children’s Oncology Group) risk and the lncRNA risk score was constructed, showing good prediction accuracy (C-index = 0.700). The prognostic ability of the nomogram was better than that of COG risk alone (AUC = 0.790 versus AUC = 0.748). GSEA analyses revealed that multiple autophagy-related gene sets are significantly enriched in the low-risk group.ConclusionsWe identified an autophagy-related four-lncRNA signature that could help to predict the PFS of NB patients. Autophagy-related gene sets are significantly enriched in low-risk group, suggesting tumor suppressive roles of autophagy in NB.https://www.frontiersin.org/articles/10.3389/fonc.2022.1014845/fullautophagyneuroblastomaprogression-free survivalprognosislong non-coding RNA
spellingShingle Jing Wang
Xinyao Meng
Ke Chen
Jiexiong Feng
An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
Frontiers in Oncology
autophagy
neuroblastoma
progression-free survival
prognosis
long non-coding RNA
title An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
title_full An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
title_fullStr An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
title_full_unstemmed An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
title_short An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
title_sort autophagy related four lncrna signature helps to predict progression free survival of neuroblastoma patients
topic autophagy
neuroblastoma
progression-free survival
prognosis
long non-coding RNA
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1014845/full
work_keys_str_mv AT jingwang anautophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT xinyaomeng anautophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT kechen anautophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT jiexiongfeng anautophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT jingwang autophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT xinyaomeng autophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT kechen autophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT jiexiongfeng autophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients